Worldwide, approximately 260 million people suffer from chronic hepatitis B which is currently incurable. However, there is now a shimmer of hope on the horizon as scientists at the DZIF have
The global increase of tuberculosis patients is alarming, particularly the increase of cases of so-called multidrug-resistant tuberculosis (MDR-TB) in which the pathogen is insensitive to the most
Jörg Janne Vehreschild started his professional career as a programmer. However, he soon decided to pursue his second passion and began his medical studies a year later. Today, at only 39, Vehreschild
Pseudomonas aeruginosa bacteria are hospital germs and are often resistant to common antibiotics. They can infect all human organs and implants, and can persist in the body for long periods of time in
Dr Silvia Portugal, Head of a DZIF junior research group, has received 1.5 million euros’ funding from the European Research Council. At the Heidelberg University Hospital, together with an
This year, the Rudolf Schülke Foundation awarded its renowned Hygiene Prize worth 15,000 € to a DZIF research team led by Dr Bernhard Krismer, Prof Andreas Peschel and Dr Alexander Zipperer from the
Globally, Brazil has been the hardest hit by the current Zika outbreak. Almost all cases of Zika-associated malformations in newborns have been reported from this country. DZIF scientists from the
Scientists at the Institute of Tropical Medicine of the University of Tübingen, the German Center for Infection Research (DZIF), and of Sanaria Inc. have developed an infection system that allows
Tsutsugamushi fever, or “scrub typhus”, is an infectious disease related to typhus, which is endemic in large parts of Asia. The disease has an estimated incidence of approximately one million cases
The first joint study to be conducted across all twelve clinical trial units at the German Center for Infection Research (DZIF) has been initiated. The aim of the study is to improve vaccine
